These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14597693)

  • 1. Safety of the treatment of interferon-alpha-induced depression.
    Loftis JM; Hauser P
    Psychosomatics; 2003; 44(6):524-6. PubMed ID: 14597693
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.
    Ann Intern Med; 2012 Jul; 157(2):I-40. PubMed ID: 22801693
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing the neuropsychiatric complications of hepatitis C treatment.
    Sockalingam S; Shammi C; Stergiopoulos V
    Br J Hosp Med (Lond); 2007 Oct; 68(10):520-5. PubMed ID: 17974293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C, interferon alfa, and depression.
    Zdilar D; Franco-Bronson K; Buchler N; Locala JA; Younossi ZM
    Hepatology; 2000 Jun; 31(6):1207-11. PubMed ID: 10827143
    [No Abstract]   [Full Text] [Related]  

  • 7. Bupropion for treatment of interferon-induced depression.
    Malek-Ahmadi P; Ghandour E
    Ann Pharmacother; 2004; 38(7-8):1202-5. PubMed ID: 15150377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon and depression. Concerning a case].
    Lozano Arroyo I; Ruiz Carriedo E
    Aten Primaria; 2004 Nov; 34(8):442. PubMed ID: 15546545
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel treatment strategies for depression in patients with hepatitis C.
    Loftis JM; Turner EH
    Psychosomatics; 2010; 51(4):357-8. PubMed ID: 20587769
    [No Abstract]   [Full Text] [Related]  

  • 10. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.
    Maddock C; Baita A; Orrù MG; Sitzia R; Costa A; Muntoni E; Farci MG; Carpiniello B; Pariante CM
    J Psychopharmacol; 2004 Mar; 18(1):41-6. PubMed ID: 15107183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-induced hepatic failure in a patient with hepatitis C.
    Lock G; Reng CM; Graeb C; Anthuber M; Wiedmann KH
    Am J Gastroenterol; 1999 Sep; 94(9):2570-1. PubMed ID: 10484034
    [No Abstract]   [Full Text] [Related]  

  • 13. Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy?
    Robaeys G; Wichers MC; De Bie J; Koek GH; Buntinx F; Van Os J
    Gut; 2009 Jan; 58(1):145; author reply 145-6. PubMed ID: 19091833
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anosmia secondary to treatment with interferon in a patient with chronic hepatitis C].
    Fernández Fernández FJ; Castiella Eguzkiza A; Tejada Calabia AM; García Bengoechea M
    Gastroenterol Hepatol; 2000 Dec; 23(10):499-500. PubMed ID: 11149229
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-induced haemolytic anaemia in hepatitis C.
    Al-Ansari M; Weilert F; Dickson G
    N Z Med J; 2008 Jul; 121(1278):78-81. PubMed ID: 18670477
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
    Chatterjee S
    J Assoc Physicians India; 2004 Jun; 52():514. PubMed ID: 15645973
    [No Abstract]   [Full Text] [Related]  

  • 18. Threshold for neutropenia in the adjustment of interferon treatment in HCV infection.
    Renou C; Harafa A; Cummins C; Muller P; Dematteï C; Jouve E; Bertrand JJ; Halfon P
    Hepatology; 2003 Apr; 37(4):949-50; author reply 950. PubMed ID: 12668993
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-induced depression in chronic hepatitis C.
    Horsmans Y
    J Antimicrob Chemother; 2006 Oct; 58(4):711-3. PubMed ID: 16951413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Myasthenia gravis due to treatment of chronic hepatitis C with a combination of interferon-alpha and ribavirin.
    Bektas M; Bektas H; Gören D; Altan M; Cetinkaya H
    Digestion; 2007; 75(4):208-9. PubMed ID: 17934275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.